drugset / Trial / NCT00144313
VaxTeen Hepatitis B Vaccine Booster Study
Phase 4
Completed
60 enrolled
Centers for Disease Control and Prevention
Alaska Native Medical Center · collab
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to determine immune status of adolescents who responded to a primary series of recombinant hepatitis B vaccine given at birth and to assess their response to a booster dose of vaccine.
Timeline
- Start
- 2005-08
- Primary completion
- —
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hepatitis B vaccine | Vaccine | — | — |